ArticleMedicine2026
Magnetic resonance imaging findings of non-mass enhancements in the breast and their association with malignancy.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our aim is to investigate the relationship between the MRI (Magnetic Resonance Imaging) features of non-mass enhancement (NME) lesions and malignancy. MRI findings of 200 and 2 NME lesions were retrospectively evaluated. Age, family history of breast cancer, lesion pathology results, and follow-up durations of the patients were obtained from medical records. Based on follow-up findings and pathology results, the lesions were classified into 3 groups as benign, high-risk, and malignant. The association between these groups and MRI features was analyzed statistically. Segmental (48.4%) and diffuse (85.7%) distribution patterns, as well as clumped (51.5%) and clustered ring (100%) enhancement patterns of NME lesions, were found to be associated with malignant lesions. According to the time-intensity curve, a Type 3 curve was associated with malignant lesions in 84.6% of cases. When evaluating the number of dynamic curves, lesions with multiple curves were considered malignant in 29.2% of cases. Regarding apparent diffusion coefficient (ADC) values, malignant and high-risk lesions had significantly lower ADC values compared to benign lesions. In this study, segmental and diffuse distribution patterns, clumped and clustered ring enhancement, Type 3 curve, and low ADC values were found to be associated with malignant lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.